top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers
Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers
Autore Kutner Andrzej
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (450 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato alpha-ketoglutarate
cell cycle
apoptosis
JNK
cell migration
cell invasion
TGF-β
VEGF
glycoconjugates
methotrexate
cancer treatment
glucose metabolism
drug design and discovery
anticancer drugs
targeted therapy
Warburg effect
antidepressants
pyrido[1,2-c]pyrimidines
dual 5-HT1A/SERT activity
drug design
anticancer activity
lung cancer
resveratrol
PRI-2191
vitamin D
active substance delivery systems
biomedical hydrogels
active substance-controlled release
genistein
hydrogels for cosmetology
hydrogels for dermatology
transdermal active substance delivery systems
histone deacetylase (HDAC)
depression
biomarker
anti-depressant therapy
human DNA topoisomerase
cancer
drug
molecular docking
synthesis
fluorine
vitamin D3
metabolite
A-ring
CD-ring
side-chain
nanoparticles
molecular modeling
oxidation mechanisms
electrochemistry
MALDI
spectroscopic data
cytotoxic study
self-assembled monolayer
gold electrode
multimodal activity
calcium-sensing receptor
enantiomer
calcimimetic
calcilytic
colon cancer
stereospecificity
HT-29
IL-8
inflammation
cyclooxygenase
1,2,4-triazole
pyridazinone
SAR
anti-inflammatory activity
antioxidant activity
ADME
anticancer drug
antimicrobial peptide (AMP)
dermaseptin
frog skin peptides
LHRH
prostate cancer
Phyllomedusa bicolor
therapeutic peptides
copper (II) complexes
thiourea
cytotoxic activity
proteome analysis
antimicrobial activity
major latex protein
Chelidonium majus
greater celandine
defense-related proteins
alkaloids
cancer cells
vitamin D receptor
split luciferase-based biosensor
CYP24A1-dependent metabolism
CYP27B1
rickets
genome editing
vitamin D biology and action
transcription
ChIP-chip analysis
distal enhancers
histone H3 acetylation
RNA polymerase II
analogue actions at genes
vitamin D hormone (1,25(OH)2D3)
latex
antiviral proteins
antimicrobial compounds
cytotoxicity
drug discovery
CRISPR/Cas9
tetrahydro-β-carbolines
Plasmodium falciparum (P. falciparum)
antimalarial
antiparasitic agents
hemolysis
vitamin D analogs
25 vitamin D 24-hydroxylase
CYP24A1
proliferation
high-grade serous ovarian cancer cells
gold
Au(III) complex
colorectal cancer
organometallic
cancer therapy
metallodrugs
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585938903321
Kutner Andrzej  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Personalized Medicine in the Field of Inflammatory Skin Disorders
Personalized Medicine in the Field of Inflammatory Skin Disorders
Autore Tampa Mircea
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (262 p.)
Soggetto topico Medicine
Soggetto non controllato sea-buckthorn seed oil
long-chain fatty acids
skin dysplastic keratinocytes
UVA
CD36
SR-B2
atopic dermatitis
eczema
JAK inhibitors
systematic review
meta-analysis
evidence-based medicine
immune-mediated skin diseases
target therapy
skin conditions and systemic inflammatory diseases
systemic sclerosis
biomarker
calumenin
S100A6
cytohesin 2
cannabinoids
inflammation
gut-lung-skin barrier
signaling pathways
inflammatory biomarkers
psoriasis vulgaris
prevalence
comorbidities
risk factors
systemic lupus erythematous
lupus nephritis
lipid peroxidation
DNA oxidation
oxidized proteins
carbohydrate oxidation
antioxidative stress strategies
biomarkers
IgY
psoriatic dermatitis
imiquimod
C57 BL/6 mice
alginate
biomaterial
dressing
fibers
hydrogel
nanofibers
commercially available
wound care
wound healing
cutaneous melanoma
epigenetic regulation
drug resistance
therapeutic targets
epigenetic therapy
immune response
Sutton nevi
halo nevi
skin tumor
psoriasis
proteome analysis
estrogen
menopause
cSCC
AK
sialylation
sialyltransferase
sialidase
COVID-19
pyoderma gangrenosum
immunosuppression
cyclosporine
corticosteroids
autoinflammatory disease
androgenic alopecia
clinical trial
hair density
platelet-rich plasma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566475103321
Tampa Mircea  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui